Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma

about

Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma.Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7

P2860

Q48132559-E76C5CCC-2369-4544-97E5-7710200FEA3D Q57801748-F54D4197-DFAB-42A5-AB3E-3D949ED7B2BB

P2860

Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma

Item

http://www.wikidata.org/entity/Q36834852

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Phase II study of erlotinib an ...... d neck squamous cell carcinoma

@en

type

Item

label

Phase II study of erlotinib an ...... d neck squamous cell carcinoma

@en

prefLabel

Phase II study of erlotinib an ...... d neck squamous cell carcinoma

@en

P1476

Phase II study of erlotinib an ...... d neck squamous cell carcinoma

@en

P2093

Chad Zender

http://www.w3.org/2001/XMLSchema#string

Charles Woods

http://www.w3.org/2001/XMLSchema#string

Jay Wasman

http://www.w3.org/2001/XMLSchema#string

Michael Gibson

http://www.w3.org/2001/XMLSchema#string

Min Yao

http://www.w3.org/2001/XMLSchema#string

Neelesh Sharma

http://www.w3.org/2001/XMLSchema#string

Panayiotis Savvides

http://www.w3.org/2001/XMLSchema#string

Pierre Lavertu

http://www.w3.org/2001/XMLSchema#string

Pingfu Fu

http://www.w3.org/2001/XMLSchema#string

Rod Rezaee

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.

Human papillomavirus and survival of patients with oropharyngeal cancer.

Cancer statistics, 2015

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Platinum-based chemotherapy plus cetuximab in head and neck cancer.

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.

P304

E1770-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HED.24313

http://www.w3.org/2001/XMLSchema#string

P478

38 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Mitchell Machtay

P577

2016-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26918562

http://www.w3.org/2001/XMLSchema#string

P932

4844765

http://www.w3.org/2001/XMLSchema#string

Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma

about

P2860

P2860

Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932